新型阿里尔碳化合物受体激素化合物用于治疗牛皮和无皮炎
1Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Atlanta, Georgia 30309, United States.
ACS medicinal chemistry letters
|June 18, 2025
概括
新型阿里碳化合物受体 (AHR) 激动剂和药物成分用于治疗像牛皮和亚托邦性皮肤炎这样的免疫媒介疾病. 这些化合物为这些炎症性皮肤疾病提供了一种新的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 免疫媒介疾病,如牛皮和亚托邦性皮肤炎,代表了重大的治疗挑战.
- 基碳化合物受体 (AHR) 是免疫反应和炎症的关键调节器.
- 针对AHR途径是一个有希望的策略来管理炎症状况.
研究的目的:
- 为了披露新型的烯碳化合物受体 (AHR) 激动剂化合物.
- 为了呈现包含这些AHR激动剂的药物成分.
- 描述这些化合物在治疗免疫媒介疾病,特别是牛皮和亚托匹性皮肤炎中的有用性.
主要方法:
- 针对AHR的新型化学实体的合成和表征.
- 含有AHR激动剂的药物成分的配方.
- 在免疫媒介疾病的临床前模型中评估治疗疗效 (细节未提供摘要).
主要成果:
- 鉴定具有强大的AHR激动剂活性的新型化合物.
- 证明这些化合物在治疗免疫媒介疾病方面的潜力.
- 开发用于制备这些治疗剂的工艺.
结论:
- 已经开发出了新型的AHR激动剂和相关的药物成分.
- 这些化合物对治疗牛皮和亚托邦性皮肤炎有前途.
- 披露的发明为患有这些免疫介导疾病的患者提供了新的治疗选择.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
260
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
260
Antiasthma Drugs: Leukotriene Modifiers
505
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
505
Antipsychotic Drugs: Typical and Atypical Agents
345
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
345
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
240
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
240
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
228
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
228


